1 Market Overview of Arthritis Monoclonal Antibodies
1.1 Arthritis Monoclonal Antibodies Market Overview
1.1.1 Arthritis Monoclonal Antibodies Product Scope
1.1.2 Market Status and Outlook
1.2 Global Arthritis Monoclonal Antibodies Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Arthritis Monoclonal Antibodies Market Size by Region (2015-2026)
1.4 Global Arthritis Monoclonal Antibodies Historic Market Size by Region (2015-2020)
1.5 Global Arthritis Monoclonal Antibodies Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026)
1.6.1 North America Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026)
1.6.2 Europe Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026)
1.6.4 Latin America Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026)
2 Arthritis Monoclonal Antibodies Market Overview by Type
2.1 Global Arthritis Monoclonal Antibodies Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Arthritis Monoclonal Antibodies Historic Market Size by Type (2015-2020)
2.3 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2021-2026)
2.4 Remicade
2.5 Humira
2.6 Enbrel
2.7 Rituxan
2.8 Orencia
2.9 Actemra
2.10 Simponi
2.11 Cimzia
3 Arthritis Monoclonal Antibodies Market Overview by Application
3.1 Global Arthritis Monoclonal Antibodies Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Arthritis Monoclonal Antibodies Historic Market Size by Application (2015-2020)
3.3 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2021-2026)
3.4 Rheumatoid Arthritis
3.5 Osteoarthritis
3.6 Psoriatic Arthritis
3.7 Ankylosing Spondylitis
3.8 Fibromyalgia
3.9 Others
4 Global Arthritis Monoclonal Antibodies Competition Analysis by Players
4.1 Global Arthritis Monoclonal Antibodies Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Monoclonal Antibodies as of 2019)
4.3 Date of Key Manufacturers Enter into Arthritis Monoclonal Antibodies Market
4.4 Global Top Players Arthritis Monoclonal Antibodies Headquarters and Area Served
4.5 Key Players Arthritis Monoclonal Antibodies Product Solution and Service
4.6 Competitive Status
4.6.1 Arthritis Monoclonal Antibodies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Company 1
5.1.1 Company 1 Profile
5.1.2 Company 1 Main Business
5.1.3 Company 1 Arthritis Monoclonal Antibodies Products, Services and Solutions
5.1.4 Company 1 Arthritis Monoclonal Antibodies Revenue (US$ Million) & (2015-2020)
5.1.5 Company 1 Recent Developments
5.2 Company 2
5.2.1 Company 2 Profile
5.2.2 Company 2 Main Business
5.2.3 Company 2 Arthritis Monoclonal Antibodies Products, Services and Solutions
5.2.4 Company 2 Arthritis Monoclonal Antibodies Revenue (US$ Million) & (2015-2020)
5.2.5 Company 2 Recent Developments
5.3 Company 3
5.5.1 Company 3 Profile
5.3.2 Company 3 Main Business
5.3.3 Company 3 Arthritis Monoclonal Antibodies Products, Services and Solutions
5.3.4 Company 3 Arthritis Monoclonal Antibodies Revenue (US$ Million) & (2015-2020)
5.3.5 Company 4 Recent Developments
5.4 Company 4
5.4.1 Company 4 Profile
5.4.2 Company 4 Main Business
5.4.3 Company 4 Arthritis Monoclonal Antibodies Products, Services and Solutions
5.4.4 Company 4 Arthritis Monoclonal Antibodies Revenue (US$ Million) & (2015-2020)
5.4.5 Company 4 Recent Developments
5.5 Company 5
5.5.1 Company 5 Profile
5.5.2 Company 5 Main Business
5.5.3 Company 5 Arthritis Monoclonal Antibodies Products, Services and Solutions
5.5.4 Company 5 Arthritis Monoclonal Antibodies Revenue (US$ Million) & (2015-2020)
5.5.5 Company 5 Recent Developments
5.6 Company 6
5.6.1 Company 6 Profile
5.6.2 Company 6 Main Business
5.6.3 Company 6 Arthritis Monoclonal Antibodies Products, Services and Solutions
5.6.4 Company 6 Arthritis Monoclonal Antibodies Revenue (US$ Million) & (2015-2020)
5.6.5 Company 6 Recent Developments
5.7 Company 7
5.7.1 Company 7 Profile
5.7.2 Company 7 Main Business
5.7.3 Company 7 Arthritis Monoclonal Antibodies Products, Services and Solutions
5.7.4 Company 7 Arthritis Monoclonal Antibodies Revenue (US$ Million) & (2015-2020)
5.7.5 Company 7 Recent Developments
5.8 Company 8
5.8.1 Company 8 Profile
5.8.2 Company 8 Main Business
5.8.3 Company 8 Arthritis Monoclonal Antibodies Products, Services and Solutions
5.8.4 Company 8 Arthritis Monoclonal Antibodies Revenue (US$ Million) & (2015-2020)
5.8.5 Company 8 Recent Developments
5.9 Company 9
5.9.1 Company 9 Profile
5.9.2 Company 9 Main Business
5.9.3 Company 9 Arthritis Monoclonal Antibodies Products, Services and Solutions
5.9.4 Company 9 Arthritis Monoclonal Antibodies Revenue (US$ Million) & (2015-2020)
5.9.5 Company 9 Recent Developments
6 North America
6.1 North America Arthritis Monoclonal Antibodies Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Arthritis Monoclonal Antibodies Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Arthritis Monoclonal Antibodies Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Arthritis Monoclonal Antibodies Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
2020-2026全球性關節炎單克隆抗體行業研究和趨勢報告
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
Table 1. Global Market Arthritis Monoclonal Antibodies Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Arthritis Monoclonal Antibodies Market Size by Region (2015-2020) (US$ Million)
Table 3. Global Arthritis Monoclonal Antibodies Market Size Share by Region (2015-2020)
Table 4. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Arthritis Monoclonal Antibodies Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Arthritis Monoclonal Antibodies Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Arthritis Monoclonal Antibodies Market Size by Type (2015-2020) (US$ Million)
Table 8. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2015-2020)
Table 9. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2021-2026)
Table 11. Global Arthritis Monoclonal Antibodies Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Arthritis Monoclonal Antibodies Market Size by Application (2015-2020) (US$ Million)
Table 13. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
Table 14. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2021-2026)
Table 16. Global Arthritis Monoclonal Antibodies Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Arthritis Monoclonal Antibodies Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Monoclonal Antibodies as of 2019)
Table 19. Date of Key Manufacturers Enter into Arthritis Monoclonal Antibodies Market
Table 20. Global Arthritis Monoclonal Antibodies Top Players Headquarters and Area Served
Table 21. Arthritis Monoclonal Antibodies Product Solution and Service
Table 22. Global Arthritis Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Company 1 Basic Information List
Table 25. Company 1 Description and Business Overview
Table 26. Company 1 Arthritis Monoclonal Antibodies Products, Services and Solutions
Table 27. Revenue (Million US$) in Arthritis Monoclonal Antibodies Business of Company 1 (2015-2020)
Table 28. Company 1 Recent Developments
Table 29. Company 2 Basic Information List
Table 30. Company 2 Description and Business Overview
Table 31. Company 2 Arthritis Monoclonal Antibodies Products, Services and Solutions
Table 32. Revenue (Million US$) in Arthritis Monoclonal Antibodies Business of Company 2 (2015-2020)
Table 33. Company 2 Recent Developments
Table 34. Company 3 Basic Information List
Table 35. Company 3 Description and Business Overview
Table 36. Company 3 Arthritis Monoclonal Antibodies Products, Services and Solutions
Table 37. Revenue (Million US$) in Arthritis Monoclonal Antibodies Business of Company 3 (2015-2020)
Table 38. Company 3 Recent Developments
Table 39. Company 4 Basic Information List
Table 40. Company 4 Description and Business Overview
Table 41. Company 4 Arthritis Monoclonal Antibodies Products, Services and Solutions
Table 42. Revenue (Million US$) in Arthritis Monoclonal Antibodies Business of Company 4 (2015-2020)
Table 43. Company 4 Recent Developments
Table 44. Company 5 Basic Information List
Table 45. Company 5 Description and Business Overview
Table 46. Company 5 Arthritis Monoclonal Antibodies Products, Services and Solutions
Table 47. Revenue (Million US$) in Arthritis Monoclonal Antibodies Business of Company 5 (2015-2020)
Table 48. Company 5 Recent Developments
Table 49. Company 6 Basic Information List
2020-2026 quánqiú xìng guānjié yán dān kèlóng kàngtǐ hángyè yánjiū hé qūshì bàogào
Table 50. Company 6 Description and Business Overview
Table 51. Company 6 Arthritis Monoclonal Antibodies Products, Services and Solutions
Table 52. Revenue (Million US$) in Arthritis Monoclonal Antibodies Business of Company 6 (2015-2020)
Table 53. Company 6 Recent Developments
Table 54. Company 7 Basic Information List
Table 55. Company 7 Description and Business Overview
Table 56. Company 7 Arthritis Monoclonal Antibodies Products, Services and Solutions
Table 57. Revenue (Million US$) in Arthritis Monoclonal Antibodies Business of Company 7 (2015-2020)
Table 58. Company 7 Recent Developments
Table 59. Company 8 Basic Information List
Table 60. Company 8 Description and Business Overview
Table 61. Company 8 Arthritis Monoclonal Antibodies Products, Services and Solutions
Table 62. Revenue (Million US$) in Arthritis Monoclonal Antibodies Business of Company 8 (2015-2020)
Table 63. Company 8 Recent Developments
Table 64. Company 9 Basic Information List
Table 65. Company 9 Description and Business Overview
Table 66. Company 9 Arthritis Monoclonal Antibodies Products, Services and Solutions
Table 67. Revenue (Million US$) in Arthritis Monoclonal Antibodies Business of Company 9 (2015-2020)
Table 68. Company 9 Recent Developments
Table 69. North America Arthritis Monoclonal Antibodies Market Size by Country (2015-2020) & (US$ Million)
Table 70. North America Arthritis Monoclonal Antibodies Market Size Share by Country (2015-2020)
Table 71. Europe Arthritis Monoclonal Antibodies Market Size by Country (2015-2020) & (US$ Million)
Table 72. Europe Arthritis Monoclonal Antibodies Market Size Share by Country (2015-2020)
Table 73. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2015-2020) & (US$ Million)
Table 74. Asia-Pacific Arthritis Monoclonal Antibodies Market Size Share by Region (2015-2020) (US$ Million)
Table 75. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2015-2020) & (US$ Million)
Table 76. Latin America Arthritis Monoclonal Antibodies Market Size Share by Country (2015-2020) (US$ Million)
Table 77. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Players (2015-2020) (US$ Million)
Table 78. Middle East & Africa Arthritis Monoclonal Antibodies Market Size Share by Players (2015-2020) (US$ Million)
Table 79. Arthritis Monoclonal Antibodies Market Trends
Table 80. Arthritis Monoclonal Antibodies Market Drivers
Table 81. Arthritis Monoclonal Antibodies Market Challenges
Table 82. Arthritis Monoclonal Antibodies Market Restriants
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Arthritis Monoclonal Antibodies Market Size Year-over-Year 2015-2026 & (US$ Million)
Figure 2. Global Arthritis Monoclonal Antibodies Market Size (US$ Million), 2015 VS 2020VS 2026
Figure 3. Global Arthritis Monoclonal Antibodies Market Share by Regions: 2020 VS 2026
Figure 4. North America Arthritis Monoclonal Antibodies Market Size (US$ Million) Growth Rate (2015-2026)
Figure 5. Europe Arthritis Monoclonal Antibodies Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Asia-Pacific Arthritis Monoclonal Antibodies Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Arthritis Monoclonal Antibodies Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Arthritis Monoclonal Antibodies Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Arthritis Monoclonal Antibodies Market Share by Type in 2020 & 2026
Figure 10. Remicade Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. Humira Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. Enbrel Market Size (US$ Million) YoY Growth (2015-2026)
Figure 13. Rituxan Market Size (US$ Million) YoY Growth (2015-2026)
Figure 14. Orencia Market Size (US$ Million) YoY Growth (2015-2026)
Figure 15. Actemra Market Size (US$ Million) YoY Growth (2015-2026)
Figure 16. Global Arthritis Monoclonal Antibodies Market Size Share by Application in 2020 & 2026
Figure 17. Rheumatoid Arthritis Market Size (US$ Million) YoY Growth (2015-2026)
Figure 18. Osteoarthritis Market Size (US$ Million) YoY Growth (2015-2026)
Figure 19. Psoriatic Arthritis Market Size (US$ Million) YoY Growth (2015-2026)
Figure 20. Ankylosing Spondylitis Market Size (US$ Million) YoY Growth (2015-2026)
2020-2026世界的関節炎モノクローナル抗體産業研究と動向報告
Figure 21. Fibromyalgia Market Size (US$ Million) YoY Growth (2015-2026)
Figure 22. Others Market Size (US$ Million) YoY Growth (2015-2026)
Figure 23. Arthritis Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Top 5 and Top 10 Players Arthritis Monoclonal Antibodies Market Share in 2019
Figure 25. United States Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Canada Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Germany Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. France Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. U.K. Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Italy Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Russia Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Nordic Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Europe Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. China Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Japan Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. South Korea Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Southeast Asia Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. India Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Australia Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Asia-Pacific Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Mexico Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Brazil Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Latin America Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Turkey Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Saudi Arabia Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. UAE Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Rest of Middle East & Africa Arthritis Monoclonal Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
略……
請您致電:400 612 8668、010-6618 1099、66182099、66183099
或Email至:KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
- 上一篇:Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Industry Research and Trends Analysis Report 2020-2026
- 電子版:《2020-2026 Global Arthritis Monoclonal Antibodies Industry Research and Trends Report》下載電子版
- 下一篇:Global Nanomaterials In Batteries and Supercapacitors Industry Research and Market Outlook Report 2020-2026